UPM-Kymmene


A strong Q1 and, more importantly, business optimism remains

03/05/19 -"2019 began on a strong note for UPM-Kymmene. Healthy performances were sustained across all divisions, with the exception of Speciality Paper – where the scope for meaningful recovery still remains. ..."

Pages
53
Language
English
Published on
03/05/19
You may also be interested by these reports :
23/04/24
Q1 was another weak quarter. While there were various challenges – pricing, demand and/or cost – like in the past few quarters, there was some ...

05/04/24
After the much-needed reality check in 2023 (especially in terms of earnings expectations), SCA seems set for a recovery – to some extent also ...

13/03/24
Despite the serious sector-wide challenges in 2023, Holmen managed to maintain healthy operating margins (>20%), which were also much-better than ...

13/03/24
The meltdown in packaging markets took its toll on MMK’s 2023 results. Although better dynamics in Packaging helped somewhat limit the gruesome ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO